
COSM — Cosmos Health Inc.
NASDAQ · Healthcare · Medical Distribution
$0.22
-$0.01 (-3.73%)
Cosmos Health Inc. (COSM) is a medical distribution company listed on NASDAQ. It is led by Grigorios Siokas, based in 141 West Jackson Boulevard, Chicago, IL, United States, 60604, with about 149 employees. Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Latest reported COSM revenue for 2026-06-30 was $19.0M. Net income was -$6.1M. Revenue was up 5.9% from 2026-03-31 to 2026-06-30. COSM currently screens at market cap $13.5M.
Use this COSM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the COSM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the COSM SEC filings page. Lician reads the product cache first so this HTML stays unique to Cosmos Health Inc. even when a live quote feed is slow.
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
COSM Key Statistics
Market Cap
$13.45M
Volume
1.03M
Previous Close
$0.21
Day Range
$0.20 – $0.21
EPS
-$0.63
Revenue
$65.27M
Net Income
-$19.14M
Gross Profit
$7.90M
Free Cash Flow
-$8.39M
Revenue Growth
+19.9%
Profit Margin
-29.3%
Debt to Equity
0.00
Employees
149
COSM Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $65.27M | $54.43M |
| Cost of Revenue | $57.38M | $50.12M |
| Gross Profit | $7.90M | $4.31M |
| Operating Income | -$16.70M | -$15.54M |
| Net Income | -$19.14M | -$16.18M |
| EPS (Diluted) | -$0.63 | -$1.17 |
Total Assets
$65.48M
Total Debt
$0.00
Shareholders' Equity
$18.42M
Cash & Equivalents
$715.67K
Operating Cash Flow
-$8.45M
Free Cash Flow
-$8.39M
Cosmos Health Inc. Company Information
- Chairman & CEO
- Grigorios Siokas
- Headquarters
- 141 West Jackson Boulevard, Chicago, IL, United States, 60604
- Website
- www.cosmosholdingsinc.com
- Phone
- 312 536 3102
- IPO / Founded
- 2012-10-11
- Sector
- Healthcare
- Industry
- Medical Distribution